Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;48(18):3396-404.
doi: 10.1016/j.ejca.2012.06.020. Epub 2012 Jul 31.

A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer

Yuki Hayashi  1 , Lianchun Xiao, Akihiro Suzuki, Mariela A Blum, Bradley Sabloff, Takashi Taketa, Dipen M Maru, James Welsh, Steven H Lin, Brian Weston, Jeffrey H Lee, Manoop S Bhutani, Wayne L Hofstetter, Stephen G Swisher, Jaffer A Ajani
Affiliations

A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer

Yuki Hayashi et al. Eur J Cancer. 2012 Dec.

Abstract

Background: The presence of malignant lymph nodes (+ypNodes) in the surgical specimen after preoperative chemoradiation (trimodality) in patients with oesophageal cancer (EC) portends a poor prognosis for overall survival (OS) and disease-free survival (DFS). Currently, none of the clinical variables highly correlates with +ypNodes. We hypothesised that a combination of clinical variables could generate a model that associates with high likelihood of +ypNodes after trimodality in EC patients.

Methods: We report on 293 consecutive EC patients who received trimodality therapy. A multivariate logistic regression analysis that included pretreatment and post-chemoradiation variables identified independent variables that were used to construct a nomogram for +ypNodes after trimodality in EC patients.

Results: Of 293 patients, 91 (31.1%) had +ypNodes. OS (p=0.0002) and DFS (p<0.0001) were shorter in patients with +ypNodes compared to those with -ypNodes. In multivariable analysis, the significant variables for +ypNodes were: baseline T-stage (odds ratio [OR], 7.145; 95% confidence interval [CI], 1.381-36.969; p=0.019), baseline N-stage (OR, 2.246; 95% CI, 1.024-4.926; p=0.044), tumour length (OR, 1.178; 95% CI, 1.024-1.357; p=0.022), induction chemotherapy (OR, 0.471; 95% CI, 0.242-0.915; p=0.026), nodal uptake on post-chemoradiation positron emission tomography (OR, 2.923; 95% CI, 1.007-8.485; p=0.049) and enlarged node(s) on post-chemoradiation computerised tomography (OR, 3.465; 95% CI, 1.549-7.753; p=0.002). The nomogram after internal validation using the bootstrap method (200 runs) yielded a high concordance index of 0.756.

Conclusion: Our nomogram highly correlates with the presence of +ypNodes after chemoradiation, however, considerably more refinement is needed before it can be implemented in the clinic.

PubMed Disclaimer

Figures

Figure1
Figure1
Sensitivity and Specificity of post chemoradiation PET and CT for lymph node metastasis. Sensitivities of both imaging are low (21.6% and 41.6%, respectively), whereas specificities are high (93.7% and 85.7%, respectively).
Figure1
Figure1
Sensitivity and Specificity of post chemoradiation PET and CT for lymph node metastasis. Sensitivities of both imaging are low (21.6% and 41.6%, respectively), whereas specificities are high (93.7% and 85.7%, respectively).
Figure2
Figure2
Nomogram to predict the probability of pathological lymph node metastasis for esophageal cancer patients using pretreatment and post chemoradiation clinical values. (Top) Points are obtained according to prognostic contribution of parameters. (Bottom) Points are translated to probability of pathological lymph node metastasis. The total points score is obtained by summing the points for each covariate of the nomogram which are baseline T, baseline N, tumor length, induction chemo, lymph node metastasis by post chomoradiation PET and CT.
Figure2
Figure2
Nomogram to predict the probability of pathological lymph node metastasis for esophageal cancer patients using pretreatment and post chemoradiation clinical values. (Top) Points are obtained according to prognostic contribution of parameters. (Bottom) Points are translated to probability of pathological lymph node metastasis. The total points score is obtained by summing the points for each covariate of the nomogram which are baseline T, baseline N, tumor length, induction chemo, lymph node metastasis by post chomoradiation PET and CT.
Figure3
Figure3
Nomogram to assess the possibility of +ypNodes after preoperative chemoradiaton in patients with oesphageal cancer undergoing surgery.
See this image and copyright information in PMC

References

    1. Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg. 2004;78(4):1177–1183. S0003497504004680 [pii] 10.1016/j.athoracsur.2004.02.068 [doi] - PubMed
    1. Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Swisher SG, Watson TJ, Blackstone EH. Worldwide esophageal cancer collaboration. Dis Esophagus. 2009;22(1):1–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop..., DES901 [pii] 10.1111/j.1442-2050.2008.00901.x. - PubMed
    1. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Jr., Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg. 2002;236(3):376–384. discussion 384-375. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PMC - PubMed
    1. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, Gebski V. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011 Epub: S1470-2045(11)70142-5 [pii] 10.1016/S1470-2045(11)70142-5 [doi] - PubMed
    1. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D, Mayer R. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086–1092. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PMC - PubMed

Publication types

MeSH terms